WallStSmart

Adapthealth Corp (AHCO)vsStryker Corporation (SYK)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 668% more annual revenue ($25.84B vs $3.36B). SYK leads profitability with a 14.4% profit margin vs -6.8%. SYK earns a higher WallStSmart Score of 67/100 (B-).

AHCO

Hold

47

out of 100

Grade: D+

Growth: 5.3Profit: 3.0Value: 6.7Quality: 4.0
Piotroski: 4/9Altman Z: 0.95

SYK

Strong Buy

67

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHCOUndervalued (+67.3%)

Margin of Safety

+67.3%

Fair Value

$32.23

Current Price

$5.64

$26.59 discount

UndervaluedFair: $32.23Overvalued
SYKSignificantly Overvalued (-17.4%)

Margin of Safety

-17.4%

Fair Value

$229.75

Current Price

$272.36

$42.61 premium

UndervaluedFair: $229.75Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHCO1 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

SYK4 strengths · Avg: 8.3/10
Market CapQuality
$104.87B9/10

Large-cap with strong market position

Operating MarginProfitability
27.0%8/10

Strong operational efficiency at 27.0%

EPS GrowthGrowth
44.1%8/10

Earnings expanding 44.1% YoY

Free Cash FlowQuality
$1.06B8/10

Generating 1.1B in free cash flow

Areas to Watch

AHCO4 concerns · Avg: 2.8/10
Market CapQuality
$761.77M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.8%3/10

Operating margin of 0.8%

Debt/EquityHealth
1.503/10

Elevated debt levels

Return on EquityProfitability
-16.6%2/10

ROE of -16.6% — below average capital efficiency

SYK2 concerns · Avg: 3.5/10
P/E RatioValuation
28.5x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AHCO

The strongest argument for AHCO centers on Price/Book. Revenue growth of 12.7% demonstrates continued momentum.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : AHCO

The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

AHCO profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.

AHCO carries more volatility with a beta of 1.39 — expect wider price swings.

AHCO is growing revenue faster at 12.7% — sustainability is the question.

SYK generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

SYK scores higher overall (67/100 vs 47/100). AHCO offers better value entry with a 67.3% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Adapthealth Corp

HEALTHCARE · MEDICAL DEVICES · USA

AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?